ImmunoGen, Inc. Stock
Equities
IMGN
US45253H1014
Biotechnology & Medical Research
Latest transcript on ImmunoGen, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Mark Enyedy
CEO | Chief Executive Officer | 60 | 16-05-15 |
Lauren White
DFI | Director of Finance/CFO | 45 | 23-09-17 |
Robert Herbst
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Enyedy
CEO | Chief Executive Officer | 60 | 16-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.59% | 2 M€ | -.--% | ||
0.22% | 7 M€ | -.--% | - | |
0.11% | 0 M€ | 0.00% | - | |
0.11% | 0 M€ | 0.00% | - |
1st Jan change | Capi. | |
---|---|---|
+48.64% | 56.65B | |
-6.44% | 39.44B | |
+37.07% | 39.03B | |
+14.28% | 26.75B | |
-11.17% | 26.86B | |
-21.40% | 19.03B | |
+25.64% | 12.26B | |
+0.96% | 12.28B | |
+27.04% | 12.04B |